Monash University, Melbourne, VIC.
Australian and New Zealand Intensive Care Research Centre, Melbourne, VIC.
Med J Aust. 2022 Oct 3;217(7):352-360. doi: 10.5694/mja2.51590. Epub 2022 Jun 9.
To compare the demographic and clinical features, management, and outcomes for patients admitted with COVID-19 to intensive care units (ICUs) during the first, second, and third waves of the pandemic in Australia.
DESIGN, SETTING, AND PARTICIPANTS: People aged 16 years or more admitted with polymerase chain reaction-confirmed COVID-19 to the 78 Australian ICUs participating in the Short Period Incidence Study of Severe Acute Respiratory Infection (SPRINT-SARI) Australia project during the first (27 February - 30 June 2020), second (1 July 2020 - 25 June 2021), and third COVID-19 waves (26 June - 1 November 2021).
Primary outcome: in-hospital mortality.
ICU mortality; ICU and hospital lengths of stay; supportive and disease-specific therapies.
2493 people (1535 men, 62%) were admitted to 59 ICUs: 214 during the first (9%), 296 during the second (12%), and 1983 during the third wave (80%). The median age was 64 (IQR, 54-72) years during the first wave, 58 (IQR, 49-68) years during the second, and 54 (IQR, 41-65) years during the third. The proportion without co-existing illnesses was largest during the third wave (41%; first wave, 32%; second wave, 29%). The proportion of ICU beds occupied by patients with COVID-19 was 2.8% (95% CI, 2.7-2.9%) during the first, 4.6% (95% CI, 4.3-5.1%) during the second, and 19.1% (95% CI, 17.9-20.2%) during the third wave. Non-invasive (42% v 15%) and prone ventilation strategies (63% v 15%) were used more frequently during the third wave than during the first two waves. Thirty patients (14%) died in hospital during the first wave, 35 (12%) during the second, and 281 (17%) during the third. After adjusting for age, illness severity, and other covariates, the risk of in-hospital mortality was similar for the first and second waves, but 9.60 (95% CI, 3.52-16.7) percentage points higher during the third than the first wave.
The demographic characteristics of patients in intensive care with COVID-19 and the treatments they received during the third pandemic wave differed from those of the first two waves. Adjusted in-hospital mortality was highest during the third wave.
比较澳大利亚 COVID-19 大流行第一、二、三波期间,入住重症监护病房(ICU)的 COVID-19 患者的人口统计学和临床特征、治疗方法和结局。
设计、地点和参与者:年龄在 16 岁及以上的患者,经聚合酶链反应确诊为 COVID-19,入住参与澳大利亚短期严重急性呼吸道感染(SPRINT-SARI)研究的 78 家澳大利亚 ICU 之一,该研究于 COVID-19 大流行第一波(2020 年 2 月 27 日至 6 月 30 日)、第二波(2020 年 7 月 1 日至 2021 年 6 月 25 日)和第三波(2021 年 6 月 26 日至 11 月 1 日)期间进行。
院内死亡率。
ICU 死亡率;ICU 和住院时间;支持性和疾病特异性治疗。
共有 2493 人(1535 名男性,62%)入住 59 家 ICU:第一波 214 人(9%),第二波 296 人(12%),第三波 1983 人(80%)。第一波的中位年龄为 64(IQR,54-72)岁,第二波为 58(IQR,49-68)岁,第三波为 54(IQR,41-65)岁。在第三波中,无合并症的患者比例最大(41%;第一波为 32%;第二波为 29%)。COVID-19 患者占用的 ICU 床位比例在第一波为 2.8%(95%CI,2.7-2.9%),第二波为 4.6%(95%CI,4.3-5.1%),第三波为 19.1%(95%CI,17.9-20.2%)。与前两波相比,第三波更常使用无创(42%比 15%)和俯卧位通气策略(63%比 15%)。第一波住院死亡 30 例(14%),第二波死亡 35 例(12%),第三波死亡 281 例(17%)。在校正年龄、疾病严重程度和其他协变量后,第一波和第二波的院内死亡率风险相似,但第三波比第一波高 9.60(95%CI,3.52-16.7)个百分点。
COVID-19 患者入住 ICU 的人口统计学特征和接受的治疗在第三波大流行期间与前两波不同。调整后的院内死亡率在第三波最高。